SCHEMBL18795997

SCHEMBL18795997

Brc1ccccc1Sc1cnc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
BIRC5 O15392 1/20 0.44
PDGFRB P09619 3/20 0.44
PDGFRA P16234 3/20 0.44
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
MGAM O43451 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP2A6 P11509 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDR P35968 1/20 0.36
PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29105728 0.77 HPGD (0.56) CYP1A2BIRC5PDGFRBPDGFRAHPGD
SCHEMBL30618060 0.77 HPGD (0.56) CYP1A2BIRC5PDGFRBPDGFRAHPGD
SCHEMBL9949544 0.76 SLC22A12 (0.47) CYP1A2PDGFRBPDGFRAHPGDHTT
SCHEMBL18796454 0.74 ALDH1A1 (0.55) HPGDHTTALDH1A1MEN1KMT2A
SCHEMBL8094448 0.74 CYP1A2 (0.57) CYP1A2BIRC5PDGFRBPDGFRAHPGD
SCHEMBL20591235 0.71 NPC1 (0.61) CYP1A2PDGFRBPDGFRAHPGDHTT
SCHEMBL28061034 0.71 PDGFRB (0.58) CYP1A2PDGFRBPDGFRAALDH1A1SMN1; SMN2
SCHEMBL24593163 0.71 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAHPGD
SCHEMBL271506 0.71 CYP1A2 (0.59) CYP1A2BIRC5PDGFRBPDGFRAHPGD
SCHEMBL271505 0.71 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 EP claimed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 US claimed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 EP claimed
CN-108349897-A Trisubstituted silylphenoxyheterocycles and analogs 拜耳作物科学股份公司 2018-07-31 CN claimed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 WO claimed
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 EP disclosed
CN-108349897-A Trisubstituted silylphenoxyheterocycles and analogs 拜耳作物科学股份公司 2018-07-31 CN disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT CYP1A2 58/4885BIRC5 826/4885PDGFRB 4258/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT CYP1A2 58/4885BIRC5 826/4885PDGFRB 4258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.